High neutrophil to lymphocyte ratio measured before starting ipilimumab treatment is associated with reduced overall survival in patients with melanoma.
J ZaragozaA CailleN BenetonG BensF ChristiannH MaillardLaurent MachetPublished in: The British journal of dermatology (2015)
High NLR (≥4) before initiating ipilimumab treatment in patients with metastatic melanoma is an independent prognostic indicator of poor survival.
Keyphrases